Almost 40% of the 146 open epilepsy clinical trials were at phase III as of March 4, 2013, Citizens United for Research in Epilepsy reported.
About 28% of epilepsy trials were at phase II, just over 21% were at phase IV, and almost 11% were at phase I, according to CURE’s search of clinicaltrials.gov.
Compared with the 146 epilepsy trials on that date, there were 85 autism trials, 176 Parkinson’s disease trials, and 196 Alzheimer’s disease trials, the report noted.
The number of research-related publications for epilepsy rose from 5,313 in 2008 to 6,049 in 2012 – an increase of 14%. In comparison, publications increased by 78% for autism, 36% for Parkinson’s, and 37% for Alzheimer’s in that time period, CURE said.
